GeneDx Holdings (WGSWW) Acquisitions (2023 - 2025)

GeneDx Holdings (WGSWW) posted quarterly Acquisitions of -$339000.0 for Q4 2025, up 97.21% sequentially from -$12.1 million in Q4 2023.

GeneDx Holdings (WGSWW) Acquisitions (2023 - 2025) Analysis & Trends

GeneDx Holdings has disclosed Acquisitions across 2 years of filings, most recently posting -$339000.0 for Q4 2025.

  • In Q4 2025, Acquisitions changed N/A year-over-year to -$339000.0; the TTM figure through Dec 2025 stood at -$339000.0 (up 97.21% YoY), while the FY2025 annual figure was $32.9 million, changed N/A from the prior year.
  • Acquisitions grew to -$339000.0 in Q4 2025, from -$12.1 million in the prior quarter.
  • Over the last five years, Acquisitions for WGSWW reached as high as -$339000.0 in Q4 2025 and fell as low as -$12.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Waters 31,055.11 Bn 31,054.65 Bn 1.11 Bn 144.00 Mn
2 Thermo Fisher Scientific 191.02 Bn 187.77 Bn 7.74 Bn 8.87 Bn
3 Danaher 137.16 Bn 131.47 Bn 3.59 Bn -
4 Idexx Laboratories 42.82 Bn 42.62 Bn 722.74 Mn -
5 Natera 39.09 Bn 37.99 Bn 696.04 Mn -
6 Agilent Technologies 37.61 Bn 35.81 Bn 990.00 Mn -
7 Iqvia Holdings 34.23 Bn 32.25 Bn 1.36 Bn 37.00 Mn
8 Illumina 28.14 Bn 26.98 Bn 721.00 Mn 415.00 Mn
9 Mettler Toledo International 26.40 Bn 26.33 Bn 555.82 Mn 2.24 Mn
10 GeneDx Holdings - - 68.21 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -339,000.00
Dec 31, 2023 -12.14 Mn